The European Commission has published its first evaluation of the application of its International Procurement Instrument (IPI), a trade defense tool designed to provide the European Union (EU) with leverage to open foreign procurement markets on a
The European Commission has published draft guidelines on the implementation of the Foreign Subsidies Regulation (FSR) and is soliciting public input on them. The FSR, which came into force in July 2023, empowers the Commission to address distortions caused
The European Union’s (EU) 27 member states agreed on June 2, 2025 to prohibit purchases of medical devices from China for five years in retaliation for China’s refusal to open its own tenders to EU firms. The ban is expected to affect contracts
In retaliation for President Trump’s imposition of tariffs on Canadian goods, the province of Ontario has significantly curbed US participation in its public sector procurement. Ontario’s premier announced on March 4 that: “American companies
This post examines two developments relating to the European Union’s (EU) implementation of its Foreign Subsidies Regulation (FSR). First is China’s findings that the EU discriminated against Chinese firms in undertaking three in-depth investigations
After a nine-month investigation, the European Commission found “clear evidence” that China is discriminating against EU medical devices and suppliers and limiting their access to government contracts. In a report, published in January, the
The European Union (EU) has initiated a review of its procurement directives (regulations) that may include the application of preferences in EU procurement. President Ursula von der Leyen proposed adoption of preferences in her political
European Commission President, Ursula von der Leyen, proposed a procurement preference for EU products in her bid for a second term. Such a move would represent a departure from the EU’s generally open procurement market and its criticism of preferences
In response to European Union (EU) investigations of Chinese firms under its recently implemented Foreign Subsidies Regulation (FSR), China has responded with its own probe of the EU. On July 10, China’s Ministry of Commerce announced it was commencing
The European Union targeted China’s procurement of medical devices in its first investigation under the International Procurement Instrument (IPI), implemented in 2022. The European Commission launched the investigation on April 24 in